Determination of HLA-A,B residue mismatch acceptability for kidneys transplanted into highly sensitized patients: a report of a collaborative study conducted during the 12th International Histocompatibility Workshop.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Transplantation

• Publication date

  1997-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199706270-00007PMID 9210498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE PREDICTIVE VALUE OF EPITOPE ANALYSIS IN HIGHLY SENSITIZED PATIENTS AWAITING RENAL TRANSPLANTATION

  1995cited by this paper
• Of payne, polymorphism, and populations

  1994cited by this paper
• Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.

  1994cited by this paper
• ASHI Rose Payne Lecture. Of Payne, polymorphism, and populations.

  1994cited by this paper
• Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.

  1994cited by this paper
• Epitope fine specificity of human anti-HLA-A2 antibodies.

  1993cited by this paper
• Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.

  1993cited by this paper
• Structural diversity in the HLA-A10 family of alleles: correlations with serology.

  1993cited by this paper
• HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.

  1992cited by this paper
• Hyperacute and acute kidney graft rejection due to antibodies against B cells.

  1992cited by this paper
• Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.

  1992cited by this paper
• Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen.

  1992cited by this paper
• Landsteiner Award. HLA epitope matching

  1992cited by this paper
• Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients.

  1991cited by this paper
• Alloantibodies against donor epidermis and early kidney transplant rejection.

  1991cited by this paper
• High cellular anti-HLA immune responsiveness accompanies the highly sensitized (high PRA) state in dialysis patients.

  1991cited by this paper
• Comparison of the humoral and cytotoxic T-lymphocyte response to individual HLA class I alloantigens in highly immunized patients.

  1991cited by this paper
• Alloantibodies: Basic and clinical concepts

  1991cited by this paper
• MULTISCREEN SERUM ANALYSIS OF HIGHLY SENSITIZED RENAL DIALYSIS PATIENTS FOR ANTIBODIES TOWARD PUBLIC AND PRIVATE CLASS I HLA DETERMINANTS: IMPLICATIONS FOR COMPUTER‐PREDICTED ACCEPTABLE AND UNACCEPTABLE DONOR MISMATCHES IN KIDNEY TRANSPLANTATION

  1990cited by this paper
• Structure, function, and diversity of class I major histocompatibility complex molecules.

  1990cited by this paper
• Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes.

  1990cited by this paper
• Novel antibodies associated with unexplained loss of renal allografts

  1990cited by this paper
• Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes.

  1990cited by this paper
• ASSOCIATION OF ANTIIDIOTYPIC ANTIBODY WITH SUCCESSFUL SECOND TRANSPLANT OF A KIDNEY SHARING HLA ANTIGENS WITH THE PREVIOUS HYPERACUTELY REJECTED FIRST KIDNEY

  1989cited by this paper
• Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30.

  1989cited by this paper
• PRESENSITIZATION AND THE RENAL ALLOGRAFT RECIPIENT

  1989cited by this paper
• Mutually exclusive public epitopes of HLA-A,B,C molecules.

  1989cited by this paper
• An expert system for the difficult renal crossmatch.

  1989cited by this paper
• Preliminary report of the American Society for Histocompatibility and Immunogenetics phase I workshop on HLA class I public epitopes.

  1987cited by this paper
• Public epitopes and the antigenic structure of the HLA molecules.

  1987cited by this paper
• Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.

  1987cited by this paper
• IMMUNOGLOBULIN CLASS AND SPECIFICITY OF ANTIBODIES CAUSING POSITIVE T CELL CROSSMATCHES: RELATIONSHIP TO RENAL TRANSPLANT OUTCOME

  1986cited by this paper
• Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies.

  1986cited by this paper
• THE VASCULAR ENDOTHELIAL CELL ANTIGEN SYSTEM

  1985cited by this paper
• Outcome of renal transplantation following a positive cross-match with historical sera: the ASHI survey.

  1985cited by this paper
• Vascular endothelial alloantigens in renal transplantation.

  1985cited by this paper
• SUCCESSFUL TRANSPLANTATION OF CYCLOSPORINE‐TREATED ALLOGRAFT RECIPIENTS WITH SEROLOGICALLY POSITIVE HISTORICAL, BUT NEGATIVE PREOPERATIVE, DONOR CROSSMATCHES

  1985cited by this paper
• Successful kidney transplantation with current-sera-negative/historical-sera-positive T cell crossmatch.

  1984cited by this paper
• Successful kidney transplantation after loss of specific antidonor HLA antibodies.

  1983cited by this paper
• Kidney preservation failure using combined Collins' solution and plasma perfusion.

  1983cited by this paper
• New approaches to donor crossmatching and successful transplantation of highly sensitized patients.

  1983cited by this paper
• Successful renal transplantation in patients with T-cell reactivity to donor.

  1982cited by this paper
• Renal allograft rejection associated with presensitization to HLA-DR antigens.

  1981cited by this paper
• Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients.

  1978cited by this paper
• FEMORAL NECK FRACTURES.

  1964cited by this paper

• Measuring alloantibodies: a matter of quantity and quality

  2019cites this paper
• Chapter 113 – Human Leukocyte Antigen and Human Neutrophil Antigen Systems

  2018cites this paper
• Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation.

  2017cites this paper
• HLA‐DR and ‐DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case–Control Study

  2015cites this paper
• Antibody-mediated Injury and Kidney Transplantation

  2014cites this paper
• Platelet transfusions to HLA‐immunized recipients: how to be or not to be matched

  2010cites this paper
• The HLA System and Histocompatibility Testing for Organ Transplantation

  2009cites this paper
• Spontaneous and treatment-induced cancer rejection in humans.

  2008cites this paper
• Spontaneous and treatment-induced cancer rejection in humans

  2008cites this paper
• Chapter 10 – Human Leukocyte and Granulocyte Antigens and Antibodies: The HLA and HNA Systems

  2007cites this paper
• Les nouvelles règles de répartition des greffons rénaux en France

  2005cites this paper
• Untersuchung von nierentransplantierten Patienten unter Berücksichtigung der HLA-Kompatibilität und der Dynamik der HLA-Antikörperbildung

  2005cites this paper
• Immunology of Leucocytes, Platelets and Plasma Components

  2005cites this paper
• [The new French rules for the attribution of renal transplants].

  2005cites this paper
• Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia

  2004cites this paper
• HLA matching for kidney transplantation.

  2004cites this paper
• LA Matching for Kidney Transplantation

  2004cites this paper
• Management of the Surgical Patient with End‐Stage Renal Disease

  2003cites this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

  2002cites this paper
• The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients.

  2002influential citation
• Prospective trial of a predictive algorithm to transplant cadaver kidneys into highly sensitized patients1

  2002cites this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.

  2002cites this paper
• Epitope analysis of the HLA class I specific antibodies: a useful tool for the detection of the acceptable mismatches for highly sensitized patients.

  2002cites this paper
• Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.

  2002cites this paper
• HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients.

  2001cites this paper
• Application of Prastat ELISA in the determination of anti‐HLA specificity for immunized patients awaiting kidney transplant: five years' experience

  2000cites this paper
• Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens

  2000cites this paper
• A limited number of HLA epitopes are recognized from HLA class I-specific antibodies detected in the serum of sensitized patients.

  2000cites this paper
• Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience

  2000cites this paper
• The national impact of the 1995 changes to the UNOS renal allocation system

  1999cites this paper
• Histocompatibility Testing in Organ Transplantation

  1999cites this paper
• Proposal for a new classification of HLA-DR alleles based on electric charges of pockets of amino acid residues.

  1998cites this paper
• Is histocompatibility testing needed for composite tissue transplantation?

  1998cites this paper